Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
66.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 4.00 (6.25%)
Market Cap: £16.08m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Director/PDMR Shareholding

30 Oct 2013 15:21

RNS Number : 7941R
MyCelx Technologies Corporation
30 October 2013
 



30 October 2013

 

Mycelx Technologies Corporation

("Mycelx" or the "Company" (AIM: MYX))

 

Dealing by Director

 

The Company announces that, on 30 October 2013, it was notified by Connie Mixon, a Director of the Company that, on 29 October 2013, she sold 25,000 common shares of US$0.025 each ("Common Shares"), representing 0.19 per cent of the present issued capital of the Company, at a price of 498p per Common Share.

 

Following this transaction, Ms. Mixon continues to be interested in 934,402 Common Shares, representing 7.05 per cent of the present issued capital of the Company, and in options over 163,017 Common Shares, of which 108,678 have vested.

 

The aggregate number of Common Shares shown for Ms. Mixon includes (a) 150,000 Common Shares held by limited liability companies controlled by Ms. Mixon; and (b) 202,646 Common Shares held by or on behalf of Ms. Mixon's children.

 

 

 

Enquiries

 

MyCelx Technologies Corporation +1 888 306 6843

Connie Mixon - CEO

Mark Clark - CFO

 

Numis Securities Limited +44 20 7260 1000

Corporate Finance/Nominated Adviser

Stuart Skinner

Jamie Loughborough

 

Corporate Broking

James Black

Ben Stoop

 

Bell Pottinger Pelham +44 20 7861 3232

Mark Antelme / Nick Lambert / Henry Lerwill

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSLLFLEIALIVIV
Date   Source Headline
3rd Jun 20267:00 amRNSAppointment of Non-Executive Director
12th May 20267:00 amRNSNew Gulf of Mexico Lease Award with Super Major
7th May 20267:00 amRNSFinal Results for the Year Ending 31 December 2025
16th Feb 202610:46 amRNSDirector Dealing
20th Jan 20267:00 amRNSTrading Update
22nd Dec 202511:27 amRNSHolding(s) in Company
7th Nov 20252:51 pmRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTrading Update & $3.9m Project Award
1st Oct 20257:00 amRNSHolding(s) in Company
23rd Sep 20255:00 pmRNSResult of Annual Meeting
23rd Sep 20257:00 amRNSAppointment of New Chairman and Succession
17th Sep 20257:00 amRNSHalf Year Results Statement
11th Sep 20257:00 amRNSClosure of Restricted Stock Line
22nd Aug 20257:00 amRNSMailing of Notice of 2025 Annual Meeting
20th Aug 20257:00 amRNSOpening of $500,000 Line of Credit
17th Jul 20257:00 amRNSTrading Update
10th Jun 20257:00 amRNSMailing of 2024 Annual Report
21st May 20253:25 pmRNSDirector Dealing
19th May 202511:33 amRNSHolding(s) in Company
15th May 202511:21 amRNSHolding(s) in Company
12th May 20257:00 amRNSFinal Results for the Year Ending 31 December 2024
6th May 20257:00 amRNSPFAS Contract Award
1st May 20257:00 amRNS-REPA Announces Actions to Combat PFAS Contamination
10th Apr 20257:00 amRNSGrant of Share Options
7th Apr 20257:00 amRNSOperational and Trading Update
30th Jan 20257:00 amRNSChange of Adviser
6th Jan 20257:00 amRNSYear-end Update
29th Oct 20247:00 amRNSProject Award
24th Sep 20247:00 amRNSHalf Year Results Statement
23rd Sep 20247:00 amRNSTrading Update
6th Sep 202411:54 amRNSHolding(s) in Company
5th Sep 20245:17 pmRNSHolding(s) in Company
30th Aug 20247:00 amRNSBroker Option
23rd Aug 202411:05 amRNSDirector Dealings & Total Voting Rights
23rd Aug 20247:00 amRNSProposed Placing and Subscription
19th Jul 202410:36 amRNSPFAS Update
9th Jul 20242:23 pmRNSResult of AGM
9th Jul 20241:39 pmRNSHolding(s) in Company
4th Jun 20247:00 amRNS2023 Annual Report & Notice of 2024 Annual Meeting
21st May 20247:00 amRNSDirector Dealing
16th May 20247:00 amRNSFinal Results for the Year Ending 31 December 2023
24th Apr 20247:00 amRNSBusiness Update
11th Apr 20247:00 amRNSEPA Publishes National Drinking Water Standards
26th Mar 20243:30 pmRNSDirector Dealing
26th Mar 20247:00 amRNSDirector Dealing
22nd Mar 20247:00 amRNSDirector Dealing
21st Mar 20247:00 amRNSDirector Dealing
18th Mar 20247:00 amRNSGrant of Share Options to Chief Financial Officer
4th Mar 20247:00 amRNSSaudi Arabia Business Operation Sale Completion
22nd Feb 20247:02 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.